Finn Jung

GW9662, a peroxisome proliferator-activated receptor gamma antagonist, attenuates the development of non-alcoholic fatty liver disease

Anja Baumann, Katharina Bürger, Annette Brandt et al. · Metabolism · 2022 · 53 citations · Full text

Medicine, Endocrinology, Pharmacology +17

Impairments of intestinal arginine and NO metabolisms trigger aging-associated intestinal barrier dysfunction and ‘inflammaging'

Annette Brandt, Anja Baumann, Angélica Hernández-Arriaga et al. · Redox Biology · 2022 · 44 citations · Full text

Life Sciences, Geriatric Medicine, Microbiology +17

Citrulline supplementation attenuates the development of non-alcoholic steatohepatitis in female mice through mechanisms involving intestinal arginase

Dragana Rajcic, Anja Baumann, Angélica Hernández-Arriaga et al. · Redox Biology · 2021 · 35 citations · Full text

Life Sciences, Nutrition, Nutritional Sciences +13

Consumption of decaffeinated coffee protects against the development of early non-alcoholic steatohepatitis: Role of intestinal barrier function

Annette Brandt, Anika Nier, Cheng Jun Jin et al. · Redox Biology · 2018 · 33 citations · Full text

Veterinary Medicine, Nutrition, Nutritional Sciences +16

Markers of Intestinal Permeability Are Rapidly Improved by Alcohol Withdrawal in Patients with Alcohol-Related Liver Disease

Finn Jung, Katharina Bürger, Raphaela Staltner et al. · Nutrients · 2021 · 33 citations · Full text

Life Sciences, Pharmacology, Alcohol Toxicology +16